Back to results
US 11,298,413 B2Granted
Vaccine compositions comprising C—C motif chemokine 22 (CCL22) or fragments thereof
AssigneeIO Biotech ApS
InventorMads Hald Andersen
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to CCL22 as a novel T cell target in cancer immunosuppression.
Claims5
An immunogenically active peptide fragment of CCL22 consisting of at the most 50 consecutive residues of SEQ ID NO:
- 12, wherein said peptide fragment is of at least 25 amino acids and contains a sequence selected from the group consisting of SEQ ID NO:
- 1, SEQ ID NO:
- 3, SEQ ID NO:
- 4, SEQ ID NO:
- 5, and SEQ ID NO:
- 11.
3 more elements
Dependencies are inferred from the claim text.